Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HIFU plus Guizhi Fuling Capsule for intramural uterine fibroids
ChiCTR2100047083Phase 4Recruiting
- Sponsor
- Hospital of Chengdu University of Traditional Chinese Medicine
- Start
- Oct 2020
- Countries
- 1
01
Overview
Phase 4, randomised trial of guizhi fuling wan in Fibromyoma (LM) (2 arms), sponsored by Hospital of Chengdu University of Traditional Chinese Medicine. Primary endpoints: Uterine size, Uterine fibroid size and 1 more. Started Oct 2020; status: recruiting.
02
Drugs
guizhi fuling wan
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on ChiCTR2100047083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100047083.